The economics of therapeutic advances: the paradigm of sympathetic suppression in chronic heart failure.
Gavras
I
I
Department of Medicine, Boston University School of Medicine, MA 02118, USA.
Manolis
A J
AJ
Gavras
H
H
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004345:Drug Industry; D017850:Economics, Pharmaceutical; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013565:Sympatholytics / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics; D013565:Sympatholytics; D003000:Clonidine